CSIMarket Company Name, Ticker, Customers, else..
 
Boundless Bio Inc   (NASDAQ: BOLD)
Other Ticker:  
 
 
Price: $1.1900 $0.05 4.386%
Day's High: $1.19 Week Perf: 0.00
Day's Low: $ 1.13 30 Day Perf: 13.33 %
Volume (M): 56 52 Wk High: $ 4.72
Volume (M$): $ 66 52 Wk Avg: $2.36
Open: $1.13 52 Wk Low: $1.00



 Market Capitalization (Millions $) 27
 Shares Outstanding (Millions) 22
 Employees 47
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -66
 Cash Flow (TTM) (Millions $) -10
 Capital Exp. (TTM) (Millions $) 3

Boundless Bio Inc
Audentes Therapeutics Inc is a biotechnology company that specializes in the development and commercialization of gene therapies for the treatment of rare muscle diseases. The company is primarily focused on developing treatments for neuromuscular conditions such as spinal muscular atrophy (SMA) and myotonic dystrophy. Audentes aims to provide innovative and potentially life-changing therapies for patients with limited treatment options. They utilize advanced genetic engineering techniques to deliver functioning copies of genes to targeted cells, thereby restoring normal function and improving patient outcomes. The company was founded in 2012 and is headquartered in San Francisco, California. Audentes Therapeutics Inc has gained recognition for its groundbreaking research and commitment to addressing unmet medical needs in the field of rare diseases.


   Company Address: 10955 Alexandria Way San Diego 92121 CA
   Company Phone Number: 766-9912   Stock Exchange / Ticker: NASDAQ BOLD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
HOOK      % 
QURE      % 
ROIV      % 
SPRO      % 
TRDA      % 
TSVT        0.2% 
• View Complete Report
   



Clinical Study

Boundless Bio Finds Stability Amid Industry Turbulence A Look at Recent Developments and Resilience in Financial Perf...

Published Thu, Dec 12 2024 9:01 PM UTC

In a landscape where many biotechnology firms are grappling with significant revenue declines, Boundless Bio Inc. has emerged with a surprising steadiness, maintaining its financial position while revamping its strategic approach. The company s recently announced pipeline and leadership updates highlight its determination to navigate through a complex and often tumultuous in...
Stocks on the Move

Audentes Therapeutics Inc Faces Underperformance Amidst Varied Market Conditions

Published Thu, Jul 11 2024 5:41 AM UTC

Audentes Therapeutics Inc, a biotechnology company specializing in gene therapy, has been experiencing a decline in share performance this week. Several factors have contributed to this underperformance, including concerns about the company s financials, market trends, the closure of a gene therapy manufacturing facility, and the emergence of competitor companies. This artic...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com